+ Follow ESRD Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 447274
[Title] => Kidney disease afflicts 10,000 Pinoys yearly
[Summary] => Kidney experts warned against being complacent on hypertension and diabetes, saying these could progress into end-stage renal disease (ESRD), which affects some 10,800 Filipinos annually.
[DatePublished] => 2009-03-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 416671
[Title] => Health experts raise alarm over rising kidney disease cases
[Summary] => Health experts expressed alarm yesterday over the rising cases of kidney disease in the country, saying that more than 10,500 Filipinos are afflicted with it.
[DatePublished] => 2008-11-20 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 138464
[Title] => Cost of end-stage renal disease reduced by losartan – new study
[Summary] => Losartan Improves Lives of Hypertensive Patients with Type 2 Diabetes and Kidney Disease by Reducing Need for Costly Dialysis and Transplantation Procedures, Resulting in Substantial Cost Savings
[DatePublished] => 2001-10-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 137976
[Title] => Cost of end-stage renal disease reduced by losartan – new study
[Summary] => Losartan Improves Lives of Hypertensive Patients with Type 2 Diabetes and Kidney Disease by Reducing Need for Costly Dialysis and Transplantation Procedures, Resulting in Substantial Cost Savings
[DatePublished] => 2001-10-26 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 135751
[Title] => Losartan significantly delays kidney disease, is excellent Cardio-Protector
[Summary] => Results from a new clinical trial show that treatment with the effective antihypertensive losartan (Cozaar) can protect the kidney and dramatically delay the progression of kidney disease, including reducing the risk of developing end-stage renal disease (ESRD).
[DatePublished] => 2001-10-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
ESRD
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 447274
[Title] => Kidney disease afflicts 10,000 Pinoys yearly
[Summary] => Kidney experts warned against being complacent on hypertension and diabetes, saying these could progress into end-stage renal disease (ESRD), which affects some 10,800 Filipinos annually.
[DatePublished] => 2009-03-12 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[1] => Array
(
[ArticleID] => 416671
[Title] => Health experts raise alarm over rising kidney disease cases
[Summary] => Health experts expressed alarm yesterday over the rising cases of kidney disease in the country, saying that more than 10,500 Filipinos are afflicted with it.
[DatePublished] => 2008-11-20 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1804896
[AuthorName] => Sheila Crisostomo
[SectionName] => Headlines
[SectionUrl] => headlines
[URL] =>
)
[2] => Array
(
[ArticleID] => 138464
[Title] => Cost of end-stage renal disease reduced by losartan – new study
[Summary] => Losartan Improves Lives of Hypertensive Patients with Type 2 Diabetes and Kidney Disease by Reducing Need for Costly Dialysis and Transplantation Procedures, Resulting in Substantial Cost Savings
[DatePublished] => 2001-10-30 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[3] => Array
(
[ArticleID] => 137976
[Title] => Cost of end-stage renal disease reduced by losartan – new study
[Summary] => Losartan Improves Lives of Hypertensive Patients with Type 2 Diabetes and Kidney Disease by Reducing Need for Costly Dialysis and Transplantation Procedures, Resulting in Substantial Cost Savings
[DatePublished] => 2001-10-26 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[4] => Array
(
[ArticleID] => 135751
[Title] => Losartan significantly delays kidney disease, is excellent Cardio-Protector
[Summary] => Results from a new clinical trial show that treatment with the effective antihypertensive losartan (Cozaar) can protect the kidney and dramatically delay the progression of kidney disease, including reducing the risk of developing end-stage renal disease (ESRD).
[DatePublished] => 2001-10-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
)
)
abtest
October 30, 2001 - 12:00am
October 26, 2001 - 12:00am
October 5, 2001 - 12:00am